会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CHRONICALLY-IMPLANTABLE ACTIVE FIXATION MEDICAL ELECTRICAL LEADS AND RELATED METHODS FOR NON-FLUOROSCOPIC IMPLANTATION
    • 慢性植入式有源固定型医用电线及相关方法非手术植入
    • WO2008108901A1
    • 2008-09-12
    • PCT/US2007/089087
    • 2007-12-28
    • MEDTRONIC, INCMARKOWITZ, H. TobyCAMPBELL-MASSA, Sean T.SCANLON, DavidKRYGER, Michael A
    • MARKOWITZ, H. TobyCAMPBELL-MASSA, Sean T.SCANLON, DavidKRYGER, Michael A
    • A61B5/053A61N1/05
    • A61N1/0573A61B2034/2053A61N1/3627
    • Bio-impedance may be used for navigation systems to chronically implant pacing and defibrillation leads in the heart using a non-fluoroscopic position sensing unit (PSU), such as a modified LocaLisa® system from Medtronic Inc., which allows for variable frequency sampling of the position of electrode of a catheter. The PSU injects small AC signals via surface electrodes in three orthogonal axes, each on a slightly different frequency (e.g., near 30 KHz). Indwelling electrodes electrically connected to the PSU resolves the magnitude of induced voltage for each of the three frequencies, thus measuring voltage for each of the three axes. Voltages are divided by induced current to yield impedance in each axis for each electrode. Impedance is proportional to position within the body. Such a system requires that a conductive material, such as a retractable helical tip-electrode, be exposed during implantation. Since the tip is retracted during implantation, this disclosure provides a modified distal portion employing at least one aperture (or "window") for fluid exposure of the helix-electrode and a deployable internal sleeve for covering the aperture(s) when the helix-electrode is extended.
    • 生物阻抗可用于导航系统,以使用非荧光位置感测单元(PSU)长期地在心脏中植入起搏和除颤引线,例如来自Medtronic Inc.的经修改的LocaLisa系统,该系统允许对 导管电极的位置。 PSU通过三个正交轴中的表面电极注入小的AC信号,每个在稍微不同的频率(例如,接近30KHz)处。 电连接到PSU的留置电极解决三个频率中的每一个的感应电压的大小,从而测量三个轴中的每一个的电压。 电压被感应电流除以每个电极的每个轴线产生阻抗。 阻抗与体内的位置成比例。 这样的系统需要在植入期间露出诸如可伸缩螺旋尖端电极的导电材料。 由于尖端在植入期间缩回,本公开提供了一种修改的远侧部分,其采用至少一个用于螺旋电极的流体暴露的孔口(或“窗口”),以及可展开的内部套筒, 电极延长。
    • 2. 发明申请
    • FUSION PACING ENHANCEMENTS
    • 融合增强
    • WO2008097959A1
    • 2008-08-14
    • PCT/US2008/053037
    • 2008-02-05
    • MEDTRONIC, INC.BURNES, John E.KLECKNER, Karin J.MULLEN, Thomas J.
    • BURNES, John E.KLECKNER, Karin J.MULLEN, Thomas J.
    • A61N1/368
    • A61N1/3627A61N1/3682A61N1/3684
    • The disclosure provides methods and apparatus of left ventricular pacing including automated adjustment of a atrio-ventricular (AV) pacing delay interval and intrinsic AV nodal conduction testing. It includes - upon expiration or reset of a programmable AV Evaluation Interval (AVEI) - performing the following: temporarily increasing a paced AV interval and a sensed AV interval and testing for adequate AV conduction and measuring an intrinsic atrio-ventricular (PR) interval for a right ventricular (RV) chamber. Thus, in the event that the AV conduction test reveals a physiologically acceptable intrinsic PR interval then storing the physiologically acceptable PR interval in a memory structure (e.g., a median P-R from one or more cardiac cycles). In the event that the AV conduction test reveals an AV conduction block condition or if unacceptably long PR intervals are revealed then a pacing mode-switch to a bi-ventricular (Bi-V) pacing mode occurs and the magnitude of the AVEI is increased.
    • 本公开提供了左心室起搏的方法和装置,包括自动调节心房(AV)起搏延迟间隔和内部AV节点传导测试。 它包括 - 在可编程AV评估间隔(AVEI)到期或复位时 - 执行以下操作:临时增加节奏的AV间隔和感测到的AV间隔,并测试足够的AV传导并测量内在房室(PR)间隔 右心室(RV)室。 因此,在AV传导测试揭示生理上可接受的内在PR间隔的情况下,然后将生理上可接受的PR间期存储在存储器结构中(例如,来自一个或多个心动周期的中值P-R)。 在AV传导测试显示AV传导阻滞状态或者如果不能接受的长PR间隔被揭示的情况下,则起搏模式切换到双心室(Bi-V)起搏模式并且AVEI的幅度增加。
    • 3. 发明申请
    • DIVERSE CAPACITOR PACKAGING FOR MAXIMIZING VOLUMETRIC EFFICIENCY FOR MEDICAL DEVICES
    • 多种电容器包装,最大限度地提高医疗器械的容积效率
    • WO2008088989A2
    • 2008-07-24
    • PCT/US2008/050579
    • 2008-01-09
    • MEDTRONIC, INC.SWANSON, Jeffery A.JOHNSON, William L.WENGER, William K.
    • SWANSON, Jeffery A.JOHNSON, William L.WENGER, William K.
    • A61N1/39
    • H01G9/26A61N1/3975H01G9/08
    • Capacitor packaging according to the disclosure provides advantages particularly in connection to compact and/or complex-shaped medical devices (e.g., having limited interior volume defined by domed and/or irregular exterior surfaces). In addition, capacitors of the type shown and described herein can be utilized in relatively compact external defibrillators, such as automatic external defibrillators or clinician-grade, automated or manually-operated external defibrillators. In one form a plurality of capacitors having substantially flat exterior surfaces are placed in an abutting relationship between at least a pair of major surfaces and the major surfaces are spaced from an opposing or adjacent surface in a non-parallel configuration. In other forms, one or more exterior surface portions have a common and/or complex radius dimension (i.e., the surfaces are curved).
    • 根据本公开的电容器封装尤其结合紧凑和/或复杂形状的医疗装置(例如,具有由圆顶和/或不规则外表面限定的内部容积)提供了优点。 另外,本文所示和所述类型的电容器可以用于相对紧凑的外部除颤器,例如自动体外除颤器或临床医师级自动或手动外部除颤器。 在一种形式中,具有基本上平坦的外表面的多个电容器以至少一对主表面之间的邻接关系放置,并且主表面以非平行配置与相对或相邻表面间隔开。 在其它形式中,一个或多个外表面部分具有共同的和/或复杂的半径尺寸(即,表面是弯曲的)。
    • 10. 发明申请
    • METHOD OF CONTINUOUS CAPTURE VERIFICATION IN CARDIAC RESYNCHRONIZATION DEVICES
    • 心脏再生装置中连续检测验证方法
    • WO2007076177A1
    • 2007-07-05
    • PCT/US2006/060812
    • 2006-11-12
    • MEDTRONIC, INC.BUSACKER, James W.SHELDON, Todd J.
    • BUSACKER, James W.SHELDON, Todd J.
    • A61N1/00
    • A61N1/3627A61N1/3684A61N1/371
    • In bi-ventricular pacing devices (including CRT devices) analysis of myocardial electrogram signals in one ventricle (e.g., a left ventricle, or "LV") can be used to infer capture or loss-of-capture (LOC) of an earlier stimulus pulse in the same ventricle, on a continuous (every pacing cycle), triggered, aperiodic and/or periodic basis. Rather than using an evoked-response principle as has been the basis of capture detection in prior art and other systems, a principle employed via the present invention uses evidence of inter-ventricular conduction (i.e., from the opposite chamber) and/or atrio-ventricular conduction as evidence of LOC, since a non-capturing pacing stimulus provided to a first chamber will allow the myocardial tissue of the first chamber to remain non-refractory and thus inter-ventricular and atrio-ventricular wavefront propagation and conduction can commence and be detected thereby revealing whether LOC has occurred.
    • 在双心室起搏装置(包括CRT装置)中,可以使用一个心室(例如,左心室或“LV”)分析心肌电图信号来推断早期刺激的捕获或丢失(LOC) 脉冲在同一个心室,连续(每个起搏周期),触发,非周期和/或周期基础。 不是使用诱发反应原理作为现有技术和其他系统中的捕获检测的基础,通过本发明采用的原理使用室间传导(即,从相对的室)和/或心室传导的证据, 心室传导作为LOC的证据,因为提供给第一腔室的非捕获起搏刺激将允许第一腔室的心肌组织保持不耐受,因此可以开始心室间和心房内波前传播和传导 从而揭示LOC是否发生。